TrivarX Limited Stock

Equities

TRI

AU0000300196

Pharmaceuticals

End-of-day quote Australian S.E. 06:00:00 2024-04-16 pm EDT 5-day change 1st Jan Change
0.024 AUD +4.35% Intraday chart for TrivarX Limited -7.69% -20.00%
Sales 2022 1.01M 647K Sales 2023 960K 618K Capitalization 4.55M 2.93M
Net income 2022 -12M -7.72M Net income 2023 -3M -1.93M EV / Sales 2022 3.15 x
Net cash position 2022 966K 622K Net cash position 2023 104K 66.79K EV / Sales 2023 4.63 x
P/E ratio 2022
-0.24 x
P/E ratio 2023
-1.11 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 71.74%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.35%
1 week-7.69%
Current month-17.24%
1 month-31.43%
3 months-7.69%
6 months+20.00%
Current year-20.00%
More quotes
1 week
0.02
Extreme 0.023
0.03
1 month
0.02
Extreme 0.023
0.03
Current year
0.02
Extreme 0.02
0.04
1 year
0.02
Extreme 0.02
0.04
3 years
0.02
Extreme 0.02
0.26
5 years
0.02
Extreme 0.02
0.64
10 years
0.02
Extreme 0.02
10.50
More quotes
Managers TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 22-12-31
Director/Board Member - 22-09-18
Members of the board TitleAgeSince
Director/Board Member - 23-02-14
Director/Board Member - 22-09-18
Chairman - 22-08-24
More insiders
Date Price Change Volume
24-04-17 0.024 +4.35% 432,610
24-04-16 0.023 -8.00% 12,500
24-04-15 0.025 0.00% 39,418
24-04-12 0.025 +4.17% 241,838
24-04-11 0.024 -7.69% 1,755,659

End-of-day quote Australian S.E., April 16, 2024

More quotes
TrivarX Limited, formerly Medibio Limited, is an Australia-based mental health technology company engaged in the use of objective measures to aid in the early detection and screening of mental health conditions. Through the Company’s corporate health product, it offers mental well-being solutions for businesses and is also developing products to serve the healthcare provider market. The principal activity of the Company is conducting clinical research, product development and early-stage commercialization of a mental health technology using objective biomarkers to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions. It has launched its consumer mobile application to help measure, monitor, and manage stress, called LUCA. LUCA is a biometric assessment tool that measures sleep stress, activity stress, and cardiac stress that allows consumers to monitor their daily stress levels through their own personal wearable device.
More about the company

Chiffre d''affaires - Rate of surprise